We show here that treatment of 3T3-L1 cells with leukemia inhibitory factor (LIF) stimulated Raf-1 activity in a time-and dose-dependent manner. Although phorbol ester failed to activate Raf-1 directly, a protein kinase C-stimulated signal was found to be necessary, but not sucient, for LIF-mediated activation of Raf-1. Elevation of intracellular cAMP levels completely blocked Raf-1 activation by LIF, but was without eect on the magnitude of mitogen-activated protein kinase (MAPK) stimulation by the cytokine, suggesting the presence of a Raf-1-independent, cAMP-insensitive MAPK kinase kinase (MAPKKK) pathway in 3T3-L1 cells. Mono Q-fractionation of LIF-stimulated 3T3-L1 extracts identi®ed a single peak of MAPKKK activity that was largely insensitive to elevated intracellular levels of cAMP, and that failed to correlate with stimulation of either Raf-1 or MEKK1 protein kinases. Our results demonstrate that LIF-mediated activation of the MAP kinase cascade in 3T3-L1 cells proceeds through both Raf-1-dependent and -independent pathways which dier in their sensitivity to inhibition by intracellular cAMP.
Introduction
Leukemia inhibitory factor (LIF) was originally described on the basis of its ability to stimulate the dierentiation of murine M1 leukemic cells into granulocytes and macrophages (Ichikawa, 1969 (Ichikawa, , 1970 . LIF is now recognized as a member of the superfamily of multifunctional cytokines capable of regulating the activities, the responsiveness, and the states of dierentiation in diverse populations of cells. For example, in addition to its eects on M1 leukemic cell dierentiation, LIF can stimulate the proliferation of embryonic stem cells, DA-1a myeloid cells, megakaryocytes, and myoblasts, induce the synthesis of acute phase proteins in hepatocytes, convert sympathetic neurons from noradrenergic to cholinergic phenotypes, and elevate the levels of circulating platelets (Hilton, 1992; Kishimoto et al., 1995; Metcalf, 1991; Taga, 1996) .
Initial studies investigating LIF receptor signaling found that cytokine-stimulated gene transcription (Ip et al., 1992; Lord et al., 1991) and M1 leukemic cell dierentiation (Lord et al., 1991) is dependent upon signaling pathways coupled to the activation of both Tyr and Ser/Thr protein kinases. Both subunits of activated heterodimeric LIF receptor complexes, namely the low anity LIF receptor a (LIFR) and gp130, associate with and stimulate members of the Jak/Tyk family of nonreceptor protein tyrosine kinases (Stahl et al., 1994) . Activation of Jak/Tyk by LIF promotes the phosphorylation on Tyr and subsequent activation of STAT1, STAT3, and STAT5 (Lai et al., 1995a; Zhong et al., 1994) , latent cytosolic transcription factors that translocate to the nucleus to initiate gene transcription at sis-inducible elements in LIFresponsive genes (Lai et al., 1995a,b; Symes et al., 1994) .
We and others (Thoma et al., 1994; Yin and Yang, 1994) have shown recently that activated LIF receptors stimulate several components of the mitogen-activated protein kinase (MAPK) cascade, including mitogen-activated protein kinase kinase (MAPKK, or MEK) , the MAPK isozymes ERK1 and ERK2, and S6 protein kinase activities against both S6 peptide and 40S ribosomes. Furthermore, maximal activation of these cascade components by LIF requires inputs from multiple signaling systems, one of which is dependent upon the presence of protein kinase C (PKC; Schiemann and Nathanson, 1994) . Stimulation of MAPK by LIF receptors and/or gp130 is thought to mediate the phosphorylation, activation, and initiation of gene induction by the basic leucine zipper containing transcription factor, NF-IL6/C/EBP-b (Baumann et al., 1992; Nakajima et al., 1993) . In addition to mediating activation of NF-IL6/C/EBP-b, stimulation of MAPK activity by LIFR and/or gp130 has been proposed to augment gene induction mediated by STAT1 and STAT3 following their phosphorylation at C-terminal Ser residues (Boulton et al., 1995; David et al., 1995; Lutticken et al., 1995; Wen et al., 1995) . Activation of the MAPK cascade in response to LIF or other factors also results in the phosphorylation of the LIFR and the regulation of LIF-mediated signal transduction (Schiemann et al., 1995) . While it is clear that the activation of MAPK can regulate LIFmediated gene transcription, the identity of the MAPKK kinase (MAPKKK) stimulated by LIF receptors and, more importantly, the signaling mechanisms responsible for regulating its activity in response to LIF are currently known.
In the present study, we ®nd that treatment of quiescent 3T3-L1 cells with LIF produced a rapid and transient stimulation of Raf-1 protein kinase activity, consistent with its role as a MAPKKK. Interestingly, we show that a PKC-stimulated signal was necessary, but not sucient, during LIF-mediated activation of Raf-1 activity. Elevation of intracellular levels of cAMP completely blocked Raf-1 activation by LIF, but was without eect on the magnitude of MAPKK and MAPK stimulation by the cytokine, suggesting the presence of a Raf-1-independent, cAMP-insensitive MAPKKK pathway in 3T3-L1 cells. Consistent with this ®nding, fractionation of LIF-stimulated 3T3-L1 extracts over Mono Q identi®ed a single peak of MAPKKK activity that was insensitive to inhibition by cAMP, and was distinct from Raf-1 and MEKK1. Our results demonstrate that LIF-mediated activation of the MAP kinase cascade in 3T3-L1 cells is a complex event that proceeds through both Raf-1-dependent and -independent pathways which dier in their sensitivity to inhibition by intracellular cAMP.
Results
Treatment of 3T3-L1 cells with LIF stimulates several components of the MAP kinase cascade, including MAPKK, the MAPK isozymes ERK1 and ERK2, and S6 protein kinase activities against both the synthetic S6 peptide (pp90 rsk ) and 40S ribosomes (pp70 S6K ) (14 ± 16). Downregulation of PKC in 3T3-L1 cells attenuates, but does not block, LIF-mediated stimulation of MAPK, suggesting that full activation of the MAP kinase cascade by LIF requires the inputs of multiple signaling pathways that converge at the level of MAPKK . However, at present no direct evidence exists describing the identity and the mechanisms responsible for regulating the isozyme(s) of MAPKKK stimulated by LIF. Because the results from several studies have clearly identi®ed Raf-1 as a mitogen-and growth factorresponsive MAPKKK in a variety of cell types (Dent et al., 1992; Howe et al., 1992; Kyriakis et al., 1992) , we asked whether or not LIF could similarly stimulate Raf-1 activity in 3T3-L1 cells. We found that stimulation of quiescent 3T3-L1 cultures with LIF produced a time- (Figure 1a ) and dose-dependent ( Figure 1b ) activation of Raf-1 activity. In response to a maximal concentration of LIF, stimulation of Raf-1 activity peaked between 2 ± 5 min, and returned rapidly to basal levels by 20 min. The kinetics of Raf-1 activation and inactivation in response to LIF occur more rapidly than those previously measured for MAPKK and MAPK (Schiemann and Nathanson, 1994 ) and thus are not only consistent with its established function as a MAPKKK, but also suggest a role for Raf-1 activity during LIF-mediated stimulation of the MAP kinase cascade in 3T3-L1 cells.
Because we have shown previously that activation of the MAP kinase cascade by LIF in 3T3-L1 cells proceeds through both PKC-dependent and -independent pathways , and because phorbol ester-sensitive PKC isozymes have been implicated as direct activators of Raf-1 (Carroll and May, 1994; Kolch et al., 1993; Sozeri et al., 1992) , we tested if both phorbol ester-sensitive PKC isozymes in 3T3-L1 cells could stimulate Raf-1 activity and if they are required during receptor-mediated stimulation of Raf-1 activity. Treatment of quiescent 3T3-L1 cells with PMA failed to signi®cantly stimulate Raf-1 activity ( Figure 2a) ; however, this treatment protocol induced signi®cant Raf-1 hyperphosphorylation as evidenced by decreased Raf-1 mobility through SDS ± PAGE (Figure 2b ). Consistent with previous observations (Wood et al., 1992 (Wood et al., , 1993 MacDonald et al., 1993; Wartmann et al., 1997) , hyperphosphorylation of Raf-1 stimulated by PMA (Figure 2b ) or by extended incubation of 3T3-L1 cells with LIF (Schiemann and Nathanson, unpublished results) correlated with the kinetics of Raf-1 inactivation and desensitization of MAPK signaling rather than Raf-1 activation. Thus, although a phorbol ester-stimulated signal is clearly transduced to Raf-1 during activation of MAPK, these results suggest that stimulation of the MAPK kinase cascade by PKC in 3T3-L1 cells proceeds through a Raf-1-independent signaling pathway. Surprisingly, chronic treatment of quiescent 3T3-L1 cells with PMA to downregulate PKC activity blocked LIFand EGF-stimulated Raf-1 activity (Figure 2c ). Taken together, these data suggest that LIF-and EGFmediated activation of Raf-1 requires a PKCstimulated signal that is necessary, but not sucient, for receptor-mediated stimulation of the MAPKKK in 3T3-L1 cells.
Increases in intracellular concentrations of cAMP can either inhibit or stimulate MAPK activity in a cell typespeci®c manner. For instance, elevations in cAMP inhibit MAPK activity in Rat-1 (Burgering et al., 1993a,b; Cook and McCormick, 1993) , aortic smooth muscle (Graves et al., 1993) , adipocytes (Svetson et al., 1993) , and CHO cells (Svetson et al., 1993) , while in COS (Faure et al., 1994) , PC12 (Frodin et al., 1994) , and Swiss 3T3 cells (Faure and Bourne, 1995) , elevations in cAMP stimulate MAPK activity. The eects of increased cAMP levels on the ability of LIF or EGF to stimulate the MAP kinase cascade were tested by incubating quiescent 3T3-L1 cells in the absence or presence of forskolin/3-isobutyl-1-methylxanthine (IBMX) for *40 min prior to agonist adminstration. As described in Materials and methods, the eectiveness of forskolin/IBMX treatment was determined by measuring the ability of cell extracts to activate PKA. This treatment protocol was found to rapidly stimulate PKA activity for up to 60 min (PKA activity was elevated from 2 ± 6-fold at 10 ± 60 min following addition of forskolin/IBMX; mean+s.e.m. of 3.14+0.47-fold, n=10). Incubation of 3T3-L1 cells with forskolin/IBMX blocked EGF-and LIF-stimulated Raf-1 activity ( Figure 3a) ; however, MAPKK activity stimulated by EGF was attenuated, but not blocked by, forskolin/IBMX treatment, while that stimulated by LIF was unaected by elevated cAMP levels ( Figure 3b ). Interestingly, increases in intracellular concentrations of cAMP did not aect MAPK activity stimulated by either agonist (Figure 3c ), suggesting the presence in 3T3-L1 cells of a LIF-and EGF-stimulated Raf-1-independent, cAMP-insensitive signaling pathway capable of activating the MAP kinase cascade.
In the course of performing these studies, it became readily apparent that the maximal levels of LIFstimulated Raf-1 activity were signi®cantly less than those stimulated by EGF (Figures 2 and 3) , and that this dierence in signaling strength found between LIF and EGF is further transduced to the level of MAPKK in 3T3-L1 cells (Figure 3b) . Surprisingly, both agonists were found to stimulate the phosphorylation of MBP to similar extents in 3T3-L1 cell extracts ( Figure 3c ). This unexpected ®nding could be explained if LIF, but not EGF, were to stimulate additional MBP protein kinases in 3T3-L1 cells. Alternatively, this result might re¯ect the ability of LIF, but not EGF, to augment the eciency of MAPKK/MAPK coupling. In order to ensure that the MBP phosphotransferase activity measured in broken cell extracts in response to either EGF or LIF was due to activation of MAPK and not additional MBP protein kinases, LIF-and EGFstimulated protein kinase activities were measured and compared in Mono Q-fractionated 3T3-L1 extracts. Stimulation of 3T3-L1 cells with either LIF or EGF activated two distinct peaks of MAPKK activity, a minor peak eluting in the¯ow-through and a major peak eluting at *65 mM NaCl (Figure 4a) . Consistent with the results obtained in broken cell assays, total LIF-stimulated MAPKK activity in Mono Q fractions was *40% of that stimulated by EGF (Figure 4a ). Immunoblots probing these peaks with anti-MEK1 antibodies demonstrated that MAPKK from EGF-stimulated cells bound more avidly to Mono Q than that from either LIF-stimulated or untreated 3T3-L1 cells (Figure 4b ). The dierences in Mono Q retention of MAPKK may re¯ect dierences in its states of phosphorylation, with increased phosphorylation and binding stimulated by EGF when compared to LIF. Recently, feedback phosphorylation of MAPKK by MAPK has been described (Brunet et al., 1994; Saito et al., 1994) ; however, dierences in Mono Q retention of MAPKK stimulated by LIF or EGF would appear to arise through mechanisms independent of MAPK-mediated PMA treatment fails to signi®cantly activate Raf-1 in 3T3-L1 cells. Quiescent 3T3-L1 cells were incubated at 378C with 100 ng/ml of LIF for 5 min (circle) or with 100 nM PMA for 0 ± 20 min (squares). Raf-1 was immunoprecipitated and assayed as described in Materials and methods. Data represents the average+s.d. of two independent experiments (b). Although unable to activate Raf-1 activity, PMA treatment to 3T3-L1 cells reduced Raf-1 mobility through SDS ± PAGE in a time-dependent manner. One-half of the immunocomplexes from (a) were fractionated through 7% SDS ± PAGE, transferred electrophoretically to Immobilon-P, and incubated with the rabbit polyclonal C-terminal anti-Raf-1 antibody (Santa Cruz Biotechnology, Inc.) at a 1/1000 dilution. The resulting Raf-1 immunocomplexes were visualized with alkaline phosphatase (ICN). (c) Eects of PKC-downregulation on EGF-or LIFstimulated Raf-1 activity in 3T3-L1 cells. Quiescent 3T3-L1 cells were treated for *18 h with 1 mM PMA to downregulate PKC activity prior to agonist administration. 3T3-L1 cells were subsequently stimulated at 378C for 5 min with 100 ng/ml of either EGF or LIF, and Raf-1 activity was determined in the resulting immunocomplexes as described in Materials and methods feedback phosphorylation, as both agonists stimulated the MAPK isozymes ERK1 and ERK2 to identical levels in Mono Q-fractionated 3T3-L1 extracts ( Figure  4c ). Thus, these data con®rm that the LIF-and EGFstimulated phosphorylation of MBP measured in clari®ed 3T3-L1 extracts was due to activation of MAPK, while suggesting further that activation of MAPK by LIF results in greater signal ampli®cation or enhanced eciency of coupling at the level of MAPKK/MAPK in 3T3-L1 cells.
Because pretreatment of quiescent 3T3-L1 cultures with forskolin/IBMX selectively blocked Raf-1 activation without aecting stimulation of MAPK mediated by LIF, we asked whether a LIF-stimulated Raf-1-independent, cAMP-insensitive MAPKKK activity could be identi®ed in Mono Q-fractionated 3T3-L1 cell extracts. Identi®cation of 3T3-L1 cell MAPKKK activity in Mono Q fractions was accomplished using a coupled protein kinase assay which measured the ability of column fractions to stimulate the enzymatic marker, MBP. Each column fraction was assayed for MBP phosphotransferase endogenous MBP phosphorylating activity, and in the presence of added inactive MAPKK/ERK2, to measure total activity. The dierence in the extent of phosphotransferase activities was used to identify potential fractions containing MAPKKK activity. Incubation of quiescent 3T3-L1 cells with either LIF (Figure 5a ) or EGF (Schiemann and Nathanson, unpublished results) consistently activated three distinct peaks of MAPKK/ERK2-dependent MBP protein kinase activity in 3T3-L1 Mono Q fractions. Based on their characteristic elution pro®le and inability to directly phosphorylate kinase-negative recombinant K97A-MEK1 (Figure 5b ), peaks 1 and 2, which eluted in the¯ow-through and at *65 mM NaCl, respectively, represent the MAPKK activity stimulated by LIF and EGF (Figures 4 and 5) . The third peak of MAPKK/ERK2-dependent activity: (1) co-eluted with ERK2 from Mono Q ( Figure 5a) ; (ii) contained true MAPKK phosphorylating activity as evidenced by its ability to directly phosphorylate K97A-MEK1 ( Figure 5b) ; (iii) was largely resistant to the inhibitory eects of forskolin/IBMX pretreatment ( Figure 5b) ; and (iv) failed to correlate with immunoreactivity against either Raf-1 or a second MAPKKK, MEKK1 (Figures 5c and d) . It is interesting that following fractionation of LIF-stimulated extracts over Mono Q, we were unable to measure Raf-1 phosphotransferase activity in column fractions of 3T3-L1 extracts. This result could be explained if during the fractionation, a cofactor necessary for Raf-1 activity were puri®ed away from its binding site in the Raf-1 activation domain. For example, ceramide has recently been shown to bind and activate Raf-1 phosphotransferase activity (45), and separation of Raf-1 from ceramide or some other component during Mono Q-fractionation may be responsible for our inability to measure its activity in fractions of either Thoma et al., 1994; Yin and Yang, 1994) , the identity of the MAPKKK(s) stimulated by LIF, and the mechanisms responsible for regulating its activity are currently unknown. Keller or presence (*, *) of 100 ng/ml of LIF for 5 min, and cytosolic extracts were prepared and fractionated over Mono Q as described in Materials and methods. The dashed lines (----) approximate the linear 120 min NaCl gradient used to elute bound proteins collected once every 2 min in 1 ml volumes. MAPKKK activity in column fractions was determined by a coupled protein kinase assay measuring the MBP phosphotransferase activity contained within individual fractions assayed in the absence (open symbols) or presence (closed symbols) of added inactive MAPKK and recombinant ERK2 as described in Materials and methods. As described in the text, the dierence in activity between that measured in the presence and absence of added MAPKK and ERK2 represents the activity due to MAPKKK in each column fraction. (b) Quiescent 3T3-L1 cells were incubated at 378C in the absence (*) or presence (*) of 100 mM forskolin and 500 mM IBMX for *45 min prior to stimulation with LIF (100 ng/ml) for 5 min at 378C. Cytosolic extracts were prepared and fractionated over Mono Q, and identi®cation of MAPKKK activity was determined by direct phosphorylation of kinase-negative recombinant K97A-MEK1 as described in Materials and methods. Seventy-®ve ml of assayed column fractions were separated on 10% SDS ± PAGE, transferred electrophoretically to Immobilon-P, and subsequently probed with antibodies against Raf-1 (c) or MEKK1 ( . Unlike previous reports demonstrating direct activation of Raf-1 protein kinase activity by PKC (Carroll and May, 1994; Kolch et al., 1993; Sozeri et al., 1992) , treatment of 3T3-L1 cells with PMA failed to signi®cantly stimulate Raf-1 activity, although inhibition of PKC activity by chronic PMA treatment blocked receptor-mediated stimulation of Raf-1 activity in 3T3-L1 cells. Thus, receptor-mediated stimulation of Raf-1 requires a PKC-stimulated signal even though the major route for PKC in stimulating the MAP kinase cascade in a 3T3-L1 cells occurs independent of pathways coupled to Raf-1 activity.
Our ®nding that elevations of intracellular cAMP concentrations in 3T3-L1 cells completely blocked Raf-1 activation without eecting the magnitude of MAPK activity stimulated by LIF or EGF is consistent with other results obtained using PC12 , Swiss 3T3 (Faure and Bourne, 1995) , and COS-7 cells (Faure et al., 1994) . Porras et al. (1994) reported that expression in 3T3-L1 cells of either activated or dominant negative Raf-1 constructs failed to stimulate or block insulin-mediated activation of MAPK/pp90 rsk , respectively. The results of Porras et al. (1994) , like ours in the current report, suggest the presence in 3T3-L1 cells of a Raf-1-independent, cAMP-insensitive pathway that is capable of targeting the activation of MAPK in 3T3-L1 cells. In support of this hypothesis, we found that chromatography of LIF-stimulated 3T3-L1 cell extracts over Mono Q produced a single peak of MAPKKK activity that was largely resistant to the inhibitory eects of cAMP. Furthermore, Western blotting of assayed Mono Q fractions demonstrated a lack of correlation between this cAMP-insensitive MAPKKK activity and the cAMP-sensitive activity of Raf-1. Interestingly, some immunoreactivity against MEKK1 is observed in Mono Q fractions containing the novel LIF-stimulated MAPKKK activity; however, based on recent reports, it is unlikely that MEKK1 represents the Raf-1-independent, cAMP-insensitive MAPKKK activity we measured in Mono Q fractions of LIF-stimulated 3T3-L1 extracts. First, full-length rat MEKK1 has recently been cloned and shown to be a *195 kDa protein kinase that partitions almost exclusively to membrane fractions (Xu et al., 1996) . Due to the manner in which our extracts of LIFstimulated 3T3-L1 cells are prepared for Mono Q chromatography (i.e., no detergent solubilization), it is highly unlikely that full-length MEKK1 is even being applied to the column. Second, activation of MEKK1 protein kinase activity preferentially stimulates the activity of JNK/SAPK and not the activity of the MAPK isozymes ERK1 and ERK2 (Minden et al., 1994; Xu et al., 1995 Xu et al., , 1996 . Activated LIF receptors couple preferentially to the stimulation of ERK1 and ERK2, not to the stimulation of JNK (Schiemann and Nathanson, unpublished results), so that it is unlikely that treatment of 3T3-L1 cells with LIF resulted in the stimulation of MEKK1 protein kinase activity. Finally, MEKK1 activity, like that of Raf-1, is sensitive to inhibition by increases in intracellular concentrations of cAMP . Taken together, it is unlikely that the cAMP-insensitive MAPKKK activity we observed in Mono Q fractions of LIF-stimulated 3T3-L1 extracts is that of MEKK1. It is possible, however, that the MEKK1 immunoreactivity we observe in Mono Q-fractionated 3T3-L1 extracts is due to cross-reactivity with another MEKKisozyme. While there is currently no evidence regarding its sensitivity to inhibition by cAMP, the recently cloned MEKK3 protein kinase, which preferentially couples to stimulation of ERK1 and ERK2 (Blank et al., 1996) , may be the LIF-stimulated, cAMP-insensitive MAPKKK activity we measure in 3T3-L1 cells.
Attempts to identify an apparent molecular weight for the LIF-stimulated, cAMP-insensitive MAPKKK activity have yielded mixed and variable results. In some experiments in which 3T3-L1 cells were pretreated with forskolin/IBMX prior to their stimulation with LIF and fractionation over Superose 12, we identi®ed a single peak of MAPKKK activity of *160 kDa, in others a single peak of 40 ± 50 kDa, and in others we see both peaks (Schiemann and Nathanson, unpublished results). The presence in some column runs of MAPKKK activities of *160 kDa and *40 ± 45 kDa, suggests that the *160 kDa activity may be the true LIF-stimulated, cAMP-insensitive MAPKKK, with the smaller molecular weight activity representing a proteolytic fragment of the larger peak. In any event, the consistent ®nding in 3T3-L1 cells that Raf-1 protein kinase activity can be dissociated from maximal stimulation of MAPK (Porras et al., 1994 , and the current study), suggests that LIF-stimulated Raf-1 activity may function in regulating a parallel pathway whose stimulation is tightly coupled with, but independent of, stimulation of MAPK.
In summary, we have shown that administration of LIF to 3T3-L1 cells results in the stimulation of Raf-1 protein kinase activity, consistent with its role as a MAPKKK. Activation of Raf-1 by LIF requires signaling inputs from PKC, and is inhibited by elevations of intracellular levels of cAMP. Inhibition of Raf-1 activity by cAMP fails to aect LIF-mediated stimulation of MAPK, and is most likely mediated by a Raf-1-independent, cAMP-insensitive MAPKKK isozyme. Our results suggest that LIF-mediated activation of the MAP kinase cascade in 3T3-L1 cells is a complex event, one that proceeds through both Raf-1-dependent and -independent pathways diering in their sensitivities to inhibition via increases in intracellular cAMP.
Materials and methods

Materials
Recombinant human LIF, murine epidermal growth factor; (EGF), and phorbol 12-myristate 13-acetate (PMA) were purchased from Preprotech (Rocky Hill, NJ), Upstate Biotechnology (Lake Placid, NY), and Sigma (St. Louis, MO), respectively, while forskolin was obtained from Calbiochem (San Diego, CA). The MAPK substrate myelin basic protein (MBP) was purchased from Sigma, while inactive recombinant ERK2, the kinase-negative recombinant proteins K52R-ERK2 and K97A-MEK1 (Lys52 or Lys97 within their ATP binding sites were mutated to Arg or Ala, respectively), and anti-MAPKK antibodies were generously provided by Drs Jean Campbell and Lee Graves (Department of Pharmacology, University of Washington, Seattle, WA). The polyclonal antibodies against Raf-1 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), while polyclonal anti-MEKK1 antibodies were generously provided by Dr Gary L Johnson (National Jewish Center for Immunology and Respiratory Medicine, Denver, CO). Dulbecco's modi®ed Eagle's medium (DMEM), fetal bovine serum (FBS), and penicillin-streptomycin were obtained from Gibco BRL (Gaithersburg, MD). All additional supplies or materials were routinely available.
Cell culture and extract preparation
Preadipocyte 3T3-L1 ®broblasts (ATCC) were cultured, rendered quiescent by incubation in serum-free DMEM, and stimulated at 378C in the presence or absence of agonist as described previously (Schiemann et al., , 1995 . Unstimulated or agonist-stimulated 3T3-L1 cells were harvested and prepared for determination of protein kinase activities either in clari®ed lysates or in Mono Qfractionated 3T3-L1 extracts as described previously Schiemann et al., 1995) . The procedure for developing the Mono Q column (HR 5/5 column, Pharmacia) was performed as described previously (Schiemann et al., 1995) .
Protein kinase assays
MAPK assays Analysis of MBP phosphorylation in either clari®ed 3T3-L1 lysates or in Mono Q fractions was performed as described previously .
MAPKK assays Agonist-stimulated MAPKK activity, determined either by direct phosphorylation of kinasenegative recombinant K52R-ERK2 or by employment of a coupled kinase assay which measured the ability of activated MAPKK to stimulate the MBP phosphotransferase activity of inactive recombinant ERK2, was measured in either clari®ed or Mono Q-fractionated 3T3-L1 extracts as described previously .
Raf-1 immunocomplex assays Raf-1 immunocomplexes from agonist-stimulated 3T3-L1 cell extracts were prepared and recovered as described (Gardner et al., 1995) . Raf-1 activity in recovered immunocomplexes was determined by employment of a coupled protein kinase assay described by Graves et al. (1993) , who demonstrated that DEAE chromatography of unstimulated cell extracts could be used to isolate a partially puri®ed preparation of inactive MAPKK that is free from contaminating ERK1 and ERK2. The ability of active Raf-1 to stimulate the phosphotransferase activity of inactive MAPKK contained in an aliquot of this DE52¯ow-through is determined by measuring the stimulation of the MBP phosphotransferase activity of inactive recombinant ERK2. Inactive MAPKK was obtained by collection of a DE52¯ow-through of quiescent 3T3-L1 extracts as described previously (Graves et al., 1993) . Protein kinase reactions were performed for 30 min at 308C in a ®nal reaction volume of 50 ml consisting of 20 mM Pipes (pH 7.0), 10 mM MgCl 2 , 20 mg/ml aprotinin, 50 mM ATP ([g-32 P]ATP, *2000 c.p.m./pmol), *1 mg of DE52¯ow-through, and 1 mg of K52R-ERK2. The reactions were terminated by addition of 17 ml of 46Laemmli sample buer, and following boiling for 5 min, phosphorylated K52R-ERK2 was separated from other cellular proteins by fractionation through 15% SDS ± PAGE. Speci®c phosphorylation of K52R-ERK2, determined after excision and scintillation counting of the appropriate substrate bands, was calculated by subtracting the radioactivity incorporated into samples incubated in the absence of immunoprecipitated Raf-1 from those incubated in its presence.
MAPKKK assays MAPKKK activity in Mono Q column fractions was identi®ed by employment of the coupled protein kinase assay described by Graves et al. (1993) . MAPKKK assays were performed at 308C by incubating equal volumes (5 ml) of column fraction (isolated as described by Graves et al., 1993) and unlabeled 46 assay buer {buer AB: ®nal assay concentrations of 25 mM bglycerophosphate, 0.5 mM dithiothreitol, 1.25 mM EGTA, 50 mM sodium vanadate, 2 mM protein kinase inhibitor, 10 mM calmidazolium, 10 mM MgCl 2 and 100 mM ATP} with 5 ml of DE52¯ow-through and 5 ml of inactive recombinant ERK2 (50 ng/tube). After 15 min, reaction mixtures were diluted to a ®nal reaction volume of 40 ml by addition of buer AB containing [g-32 P]ATP (*2000 c.p.m./ pmol) and MBP (®nal concentration of 0.25 mg/ml), and were allowed to proceed for an additional 15 min at 308C. Protein kinase reactions were terminated by spotting the reaction mixture onto P81 phosphocellulose paper (Whatman) and, following six washes in 125 mM phosphoric acid, the papers were dried and subjected to scintillation counting. Speci®c MAPKKK activity was calculated by subtracting the radioactivity measured in samples incubated in the absence of added DE52¯ow-through and ERK2 from those incubated in their presence.
To con®rm that identi®ed peaks of MAPKKK activity contained a true MAPKK-phosphorylating activity, protein kinase assays measuring the direct phosphorylation of the kinase-negative recombinant K97A-MEK were performed on Mono Q column fractions of LIF-stimulated 3T3-L1 cell extracts. Brie¯y, K97A-MEK phosphorylation assays were performed in a ®nal reaction volume of 40 ml containing 1 mg of K97A-MEK1 and 20 ml of column fraction. Protein kinase reactions were initiated by addition of 10 ml of labeled 46 buer AB, and were allowed to proceed for 30 min at 308C. Protein kinase reactions were subsequently terminated by addition of 17 ml of 46 Laemmli sample buer, and after boiling for 5 min, phosphorylated K97A-MEK was separated from other cellular proteins by fractionation through 10% SDS-polyacrylamide gel electrophoresis (PAGE). Speci®c phosphorylation of K97A-MEK was determined after autoradiography by excision and scintillation counting of the appropriate substrate bands.
cAMP-dependent protein kinase (PKA) assay The ability of PKA to phosphorylate the synthetic substrate kemptide was determined as described by Graves et al. (1993) . This assay measures the activation of PKA in response to cellular cAMP carried over into the reaction mix and thus determines the eectiveness of drug treatment in increasing the level of intracellular cAMP.
Western blotting of Mono Q chromatography fractions
Western blotting of Mono Q-fractionated 3T3-L1 cell extracts for the presence of either Raf-1 or MEKK1 was performed by electrophoretic transfer to Immobilon-P (Millipore) of 75 ml of column fraction previously separated through 10% SDS ± PAGE. After blockade of nonspeci®c binding sites by incubation in TBS (10 mM Tris, 150 mM NaCl, pH 8.0) supplemented with 5% bovine serum albumin, the immunoblots were probed with antiRaf-1 antibodies (1 mg/ml), and then stripped and reprobed with anti-MEKK1 antibodies (1/1000 dilution) as indi-cated. Proteins were visualized with enhanced chemiluminescence according to the manufacturer's recommendations (Renaissance, Du Pont New England Nuclear).
